fluorouracil with calcipotriene
Showing 1 - 25 of 1,120
Actinic Keratosis Trial in United States (Biopsy, Calcipotriene, Fluorouracil)
Not yet recruiting
- Actinic Keratosis
- Biopsy
- +2 more
-
Tucson, Arizona
- +3 more
Jan 25, 2023
Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ Trial in Boston, Quincy (Combination cream of 5-fluorouracil
Recruiting
- Superficial Basal Cell Carcinoma
- Squamous Cell Carcinoma in Situ
- Combination cream of 5-fluorouracil and calcipotriene
- 5-fluorouracil cream
-
Boston, MassachusettsBoston Medical Center Dermatology Clinic
Nov 9, 2022
Squamous Cell Carcinoma Trial in Roanoke (Combination topical 5-fluorouracil 5% / calcipotriene 0.005% cream, Nourivan Base
Recruiting
- Squamous Cell Carcinoma
- Combination topical 5-fluorouracil 5% / calcipotriene 0.005% cream
- Nourivan Base Cream
-
Roanoke, VirginiaCarilion Clinic Dermatology and Mohs Surgery
Apr 26, 2021
Immunotherapy, Cutaneous Squamous Cell Carcinoma, Actinic Keratoses Trial in Boston, Saint Louis (Calcipotriol Only Product in
Not yet recruiting
- Immunotherapy
- +4 more
- Calcipotriol Only Product in Cutaneous Dose Form
- +2 more
-
Boston, Massachusetts
- +1 more
Apr 5, 2022
Actinic Keratoses Trial in New Orleans (Calcipotriene 0.005% Foam, Efudex 5% Topical Cream)
Terminated
- Actinic Keratoses
- Calcipotriene 0.005% Foam
- Efudex 5% Topical Cream
-
New Orleans, LouisianaTulane University Medical Center
Dec 3, 2020
Cutaneous Squamous Cell Carcinoma, Actinic Keratoses, Skin Cancer Trial in Boston, Saint Louis (Calcipotriol Only Product in
Not yet recruiting
- Cutaneous Squamous Cell Carcinoma
- +4 more
- Calcipotriol Only Product in Cutaneous Dose Form
- +2 more
-
Boston, Massachusetts
- +1 more
Apr 5, 2022
Effectiveness, and Safety ofFixed-dose Combination of
Not yet recruiting
- Plaque Psoriasis
- CAL/BDP PAD Cream
- (no location specified)
Mar 31, 2023
Clinical Stage I Esophageal Adenocarcinoma AJCC v8, Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8, Clinical
Not yet recruiting
- Clinical Stage I Esophageal Adenocarcinoma AJCC v8
- +5 more
- Biospecimen Collection
- +9 more
-
Scottsdale, Arizona
- +2 more
Oct 11, 2023
Neoadjuvent, PD-1 Inhibitor, Chemo Trial in Xi'an (Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin)
Recruiting
- Neoadjuvent
- +3 more
- Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin
-
Xi'an, Shaanxi, China
- +2 more
Aug 17, 2023
Breast Cancer Trial in Boston (Topical Calcipotriene Ointment, Topical Vaseline)
Recruiting
- Breast Cancer
- Topical Calcipotriene Ointment
- Topical Vaseline
-
Boston, MassachusettsMassachusetts General Hospital
Nov 2, 2021
Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Squamous Cell Carcinoma Trial in Philadelphia (Capecitabine,
Active, not recruiting
- Anal Basaloid Carcinoma
- +6 more
- Capecitabine
- +6 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jan 3, 2023
Metastatic Colorectal Cancer Trial in Nanchang (Fruquintinib)
Recruiting
- Metastatic Colorectal Cancer
-
Nanchang, Jiangxi, ChinaThe First Affiliated Hospital of Nanchang University
Nov 1, 2023
Odontogenic Keratocyst Trial in Belgrade (procedure, diagnostic test, drug)
Enrolling by invitation
- Odontogenic Keratocyst
- Enucleation
- +3 more
-
Belgrade, SerbiaSchool of Dental Medicine
Oct 19, 2023
Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guangzhou (bTAE-HAIC, Lenvatinib, Sintilimab)
Not yet recruiting
- Liver Diseases
- +4 more
- bTAE-HAIC
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 30, 2023
Rectal Cancer Trial in Osaka (radiation, drug, procedure)
Recruiting
- Rectal Cancer
- Radiation
- +2 more
-
Osaka, Japan
- +1 more
Jul 1, 2023
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma, Advanced Gastroesophageal Junction Adenocarcinoma Trial
Not yet recruiting
- Advanced Esophageal Adenocarcinoma
- +14 more
- Fluorouracil
- +8 more
- (no location specified)
Jan 3, 2023
Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in
Not yet recruiting
- Pancreatic Adenocarcinoma Metastatic
-
Pessac, FranceCHU Bordeaux
Aug 17, 2023
Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,
Recruiting
- Clinical Stage II Esophageal Adenocarcinoma AJCC v8
- +23 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 5, 2022
Liver Diseases, Hepatocellular Carcinoma, Immunotherapy Trial in Guanzhou (bTAE-HAIC, Lenvatinib, Camrelizumab)
Not yet recruiting
- Liver Diseases
- +4 more
- bTAE-HAIC
- +2 more
-
Guanzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Sep 24, 2023
Colon Mucinous Adenocarcinoma, Colon Signet Ring Cell Adenocarcinoma, Lynch Syndrome Trial in Worldwide (biological, drug,
Active, not recruiting
- Colon Mucinous Adenocarcinoma
- +5 more
- Bevacizumab
- +4 more
-
Anniston, Alabama
- +935 more
Oct 18, 2022
Esophageal Squamous Cell Carcinoma Trial (LY01015, Fluorouracil, Cisplatin)
Not yet recruiting
- Esophageal Squamous Cell Carcinoma
- LY01015
- +3 more
- (no location specified)
Aug 28, 2023
Vitiligo, Topical Fluorouracil, Effervescent Mixture Trial in Cairo (a new effervescent mixture 5-florouracil formula,
Not yet recruiting
- Vitiligo
- +2 more
- a new effervescent mixture 5-florouracil formula
- 5-Fluorouracil plain powder
-
Cairo, EgyptFacualty of Pharmacy, Al Azhar University
Sep 12, 2022
Unresectable Metastatic Colorectal Cancer Trial (ABBV-400, Bevacizumab, Folinic Acid)
Not yet recruiting
- Unresectable Metastatic Colorectal Cancer
- ABBV-400
- +4 more
- (no location specified)
Oct 25, 2023
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 19, 2022